The Myeloproliferative Neoplasms Channel on VJHemOnc is an independent medical education platform, supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
EHA 2020 | Mastocytosis: impact of COVID-19 on clinical practice
Cem Akin
• 10 Jun 2020
Cem Akin MD, PhD, of the University of Michigan, Ann Arbor, MI, discusses the impact of COVID-19 in mastocytosis clinical practice. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).
